Fintel reports that on February 3, 2025, Redburn Atlantic upgraded their outlook for DexCom (NasdaqGS:DXCM) from Neutral to ...

The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...

DexCom (NASDAQ:DXCM) shares received an optimistic update from Redburn-Atlantic, with analyst Issie Kirby (NYSE:KEX) upgrading the stock from Neutral to Buy and increasing the price target to $115 ...

Breakfast is an ambulatory event of either a V8 juice (vegetable serving) or an Ensure high protein drink.

Baillie Gifford's 13F portfolio shows changes in top holdings like Amazon and NVIDIA, with increased stakes in SEA Ltd. Read ...

Let me tell you about my daily routine. My biological alarm clock has me consistently awake at around 2:00 am and again ...

DexCom Inc. closed 38.30% below its 52-week high of $142.00, which the company achieved on March 26th.

Geneos Wealth Management Inc. lessened its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.6% in the ...

Exchange Traded Concepts LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the ...

As eight-year-old Elizabeth Struhs lay dying from a diabetes-induced ketoacidosis, the medicine that could have saved her ...

On Monday, DexCom Inc (DXCM) stock saw a decline, ending the day at $87.53 which represents a decrease of $-1.22 or -1.37% from the prior close of $88.75. The stock opened at $88.58 and touched a low ...